Richard is Professor of Infectious Disease Modelling in the Centre for the Mathematical Modelling of Infectious Diseases and the TB Centre at the London School of Hygiene and Tropical Medicine. He was awarded a PhD in infectious disease modelling in 2006, led the establishment of the LSHTM’s Centre for the Mathematical Modelling of Infectious Diseases in 2007, and was awarded a Methodology Research Fellowship from the Medical Research Council in 2009. He leads the LSHTM TB Modelling Group.
Dr White’s research focus is the mathematical and statistical modelling of the transmission and control of infectious diseases, particularly TB and HIV. He has co-authored over 100 peer-reviewed scientific publications and an introductory infectious disease modelling book. He is currently PI/LSHTM PI of six research grants: this TB Modelling and Analysis Consortium, Determining the importance of different locations to Mycobacterium tuberculosis transmission in high tuberculosis burden settings (MRC), A Clinical Trial of a Correlate of Risk Targeted Screen & Treat Strategy to Impact TB Control (BMGF), The development of a mathematical modelling framework to predict the best dose in humans for TB vaccines using animal data (Aeras), 'Methods for allocative efficiency of the Global Fund TB, HIV and Malaria Country Grants' (USAID), and 'Data utilization and modelling to support TB control policy and practice in South Africa' (BMGF).
David Dowdy is an epidemiologist and practicing general internist whose research merges expertise in classical epidemiology, economic evaluation, infectious disease modeling, and translation of science into policy. David received his MD and PhD (in epidemiology) at Johns Hopkins in 2008 and completed his residency training in internal medicine at UCSF in 2011. His primary body of work involves modeling the population-level impact and cost-effectiveness of diagnostic interventions for tuberculosis (TB). Other efforts and areas of interest include heterogeneity in TB transmission, active TB case-finding, development of "user-friendly" modeling tools for TB, costing of HIV prevention interventions, and evaluation of TB therapeutics and vaccines.
Philip Eckhoff is currently the Principal Investigator of the disease modeling team at Intellectual Ventures in Bellevue Washington. This group develops computer simulations of malaria, polio, and other disease transmission dynamics to assist public health professionals and other scientists in planning eradication of different diseases. These simulations have resolution of individuals but cover large geographic areas and are focused on studying all phases of a Global Eradication campaign. Beyond modeling disease Eradication, his research interests include technologies for improved public health in the developing world and other global development issues, such as vaccine delivery and sanitation.
Philip completed his undergraduate studies at University of Texas, Austin receiving degrees in pure mathematics and aerospace engineering. At UT, he participated on the winning design team for FASTRAC, a student designed and built satellite for the Nanosat-3 competition. Philip began his graduate studies at Princeton University in applied and computational mathematics, receiving his PhD in 2009. At Princeton, his work focused on computational neuroscience and biophysics-motivated models of decision making. While at Princeton, he began work on malaria and mathematical models of disease transmission, having had malaria frequently while growing up in Haiti.
Philip received a Special Achievement Award by a Hertz Fellow in 2009 for his work on Malaria Modeling. He enjoys hiking and kayaking in the Pacific Northwest and attending Seattle Symphony performances.
Katherine works as at WHO's Global TB Programme as the TB Monitoring and Evaluation Co-ordinator
Michael Kimerling, joined KNCV Tuberculosis Foundation in the new role of Technical Director on April 1, 2015. He leads the newly formed Technical Division and will be part of KNCV’s Management Team. The new function is part of the restructuring of KNCV, which was taken in hand to optimize the technical advisory capacity and balance this with outstanding project management. The new organizational structure has three divisions working closely together: Finance, Operations (project management) and Technical Services
Michael was Senior Program Officer in Global Health for TB Delivery at the Bill and Melinda Gates Foundation, and Affiliate Professor in Global Health at the University of Washington,
Nick Menzies is Assistant Professor of Global Health in the Department of Global Health and Population at the Harvard Chan School of Public Health, and faculty of the Harvard Center for Health Decision Science. Professor Menzies uses decision science and quantitative research to understand the consequences of major policy change, and help design effective disease control programs where resources are limited. His research combines empirical data with mathematical modeling to examine infectious disease control policy in high burden settings, currently focusing on the intersection of HIV and TB epidemics in sub-Saharan Africa and other high-burden settings.
James Trauer is Head of the Epidemiological Modelling Unit at the School of Public Health and Preventive Medicine, Monash University. There he undertakes research to improve the effectiveness of infectious disease control programs through modelling, with a particular focus on tuberculosis (TB) and emerging infections. He also coordinates the School’s growing focus on modelling of non-communicable diseases and demographic trends.
James completed his PhD in 2015 under the supervision of Professor Emma McBryde, now of James Cook University, with whom he continues to collaborate closely as part of the Australian Tuberculosis Modelling Network (AuTuMN). This cross-institutional group provides country-level support for TB control programs in high-burden countries and has recently undertaked such analyses in Fiji, the Philippines and Bulgaria, while past modelling work has simulated TB responses in Papua New Guinea, India, China and South Africa. These projects have been undertaken with support of the National TB Programs of the respective countries, the Global Fund to Fight AIDS, TB and Malaria and Médecins sans Frontières.
He works clinically as a respiratory, sleep and general physician, undertaking regular care for TB patients at the Royal Melbourne Hospital, as well as being involved with the public health and policy response to TB as a public health physician for the Victorian Tuberculosis Program.
James joins us as a rotating member and will be on the Committee from August 2017 to February 2018.
Anna Vassall is a health economist with around twenty years experience economic analysis. She first worked in the NHS supporting funding/contracting. She then took an MSc in Health Planning and Financing at the LSHTM, thereafter working for DFID as a health economist in the UK and Pakistan. This was followed by a period at Royal Tropical Institute (KIT) Amsterdam working on health planning and financing, aid effectiveness and the cost-effectiveness of tuberculosis and reproductive health in a wide range of low and middle income countries. For the last few years, she has been managing European Community and World Bank funded health sector reform and development projects in Yemen, East Timor, Syria and Sudan. Her PhD is in the economic evaluation of tuberculosis control.
Anna's research interests are in the economic evaluation of HIV (with a focus on efficiency, integration, scaling-up and systems costs estimation) and aid effectiveness. She is a member of the Social and Mathematical Epidemiology Group, within Global Health and Development.
David Wilson, PhD in infectious disease modeling, is a Senior Program Officer in Decision Sciences at the Bill & Melinda Gates Foundation. Prior to joining the Foundation, David was a Professor of Modeling & Health Economics at the Burnet Institute and Monash University in Australia, and CEO of the Optima Consortium for Decision Science, where he was leading teams conducting applied research into improving efficiency in health responses. In 17 years as an academic prior to joining the Gates Foundation, his dominant focus was on allocative efficiency for major infectious diseases (with special focus on HIV) although has also worked in other areas of health and complementary methods. This includes, for six years being the Head of Public Health Surveillance in Australia for blood-borne viruses and STIs. Most of his work has been conducted to support LMIC governments and their local or global partners to make better decisions for health through the generation, synthesis and promotion of quantitative evidence including surveillance, modeling, health economics and resource allocation, strategic target setting, supporting strategic purchasing and financing, and capacity building in countries for the translation of evidence to policy and programming. Working in approximately 40 countries on all continents, he has published over 230 scientific papers and delivered over 500 scientific addresses.
Previous Committee Members
Christopher Dye is Director of Health Information in the Office of HIV/AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases at the World Health Organization. He began professional life as an ecologist in the UK, having been awarded a first-class degree in biology from the University of York and a DPhil in zoology from the University of Oxford. After developing an interest in infectious diseases at Imperial College London, he moved to the London School of Hygiene and Tropical Medicine to bring his research closer to public health. He was head of the School’s Vector Biology and Epidemiology Unit until 1996, carrying out research on leishmaniasis, malaria, rabies and other infectious and zoonotic diseases in Africa, Asia and South America.
In 1996, he joined the World Health Organization where he has developed methods for using national surveillance and survey data to study the large-scale dynamics and control of tuberculosis (TB) and other communicable diseases. Working with governments and other agencies he is continuously engaged in the process of translating science into health policy. From 2006–2009, he was Professor of Physic at Gresham College, 35th in a lineage of professors that have been giving public lectures in the City of London since 1597. He is a Visiting Professor of Zoology at the University of Oxford, a member of the Board of Reviewing Editors for Science, and a Fellow of the Royal Society and of the UK Academy of Medical Sciences.
Dr. Martien Borgdorff is a Director at The Centers for Disease Control and Prevention (CDC) Western Branch, Kenya, based at the KEMRI’s Centre for Global Health Research, Kisian, Kisumu.
Previously, Dr. Borgdorff worked as Executive Director of the KNCV Tuberculosis Foundation in The Hague. Dr Borgdorff also worked as the Head of the Cluster Infectious Diseases at the Municipal Health Service of Amsterdam and professor of epidemiology at the University of Amsterdam.
Dr. Borgdorff is an internationally renowned expert in tuberculosis epidemiology. He is a medical doctor (MD 1980, Utrecht), with training in Community Health in Developing Countries (MSc 1986, London) and a PhD in epidemiology (1994, Amsterdam).
He has published more than 160 papers, the majority of which on tuberculosis epidemiology and his H- index is 30 He has been resident in Africa (Zimbabwe and Tanzania) for more than eight years and has worked as a consultant in twenty developing countries. Dr. Borgdorff has worked for the World Health Organization (Geneva and Harare), Royal Tropical Institute, Amsterdam, and National Institute of Public Health and the Environment, Bilthoven. Dr. Borgdorff has also worked as the Editor-in-Chief of the International Journal on Tuberculosis and Lung Disease.
Geoff Garnett is Professor of Microparasite Epidemiology at Imperial College London. His main area of research is the epidemiology and control of sexually transmitted infections. The development and analysis of mathematical models of the transmission dynamics of STDs provides a framework to analyse surveillance and survey data and observational cohort studies. Prof. Garnett’s main aims have been to develop and understanding of the patterns of sexual behaviour involved in STI spread and to understand the potential impact of behavioural and health care interventions.
With a background in population ecology, Prof. Garnett’s PhD was on the epidemiology of varicella-zoster virus; exploring the relationship between chickenpox and shingles and the impact of the varicella vaccine. Before taking up a faculty post at Imperial College London, Prof. Garnett held a Wellcome Trust Training Fellowship in Mathematical Biology and a Royal Society University Research Fellowship
Since 1990 Prof. Garnett has worked on the broad area of HIV and STD epidemiology, with projects on the demographic impact of AIDS; modelling sexual partner networks; the epidemiology of HIV, gonorrhoea, syphilis, trichomoniasis, herpes-simplex virus and human papilloma virus. Recent work has focussed on the potential impact of HPV vaccines the epidemiological consequences of antiretroviral treatments and the evaluation of HIV Prevention programmes.
Prof. Garnett has been an investigator on community randomised trials of HIV interventions in Zimbabwe and Peru and has been involved in the design and analysis of a number of sexual behaviour surveys in developed and developing countries. As Chair of the UNAIDS Reference Group on Estimates, Models and Projections Prof. Garnett has played a part in developing the methods used in HIV surveillance globally.
Damian Walker PhD
Damian Walker is a Senior Program Officer at the Bill & Melinda Gates Foundation, where he works on the cost-effectiveness of health interventions and technologies. His portfolio of grants includes efforts to set disease control priorities globally, as well as assessments of the cost-effectiveness of new vaccines, and HIV treatment and prevention interventions at the national level.
He led the development of the foundation's reference case methodology for cost-effectiveness analysis (in partnership with NICE International). He also manages a recent grant awarded to NICE International - the international Decision Support Initiative - to support low- and middle-income governments in making resource allocation decisions for healthcare (co-funded with the UK's Department for International Development).
Prior to the joining the foundation in July 2010, Damian was an Associate Professor in the Department of International Health, Bloomberg School of Public Health, Johns Hopkins University. Damian has published over 80 peer-reviewed journals, and a dozen book chapters. Damian holds a B.Sc. in economics and an M.Sc. in health economics from the University of York, and a Ph.D. in health economics from the London School of Hygiene & Tropical Medicine